|
|
|
Volumn 43, Issue 1113, 2001, Pages 81-82
|
|
Influenza prevention 2001-2002
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMANTADINE;
ANTIHISTAMINIC AGENT;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
INFLUENZA VACCINE;
OSELTAMIVIR;
RIMANTADINE;
CHRONIC DISEASE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG APPROVAL;
DRUG COST;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INDICATION;
DRUG INDUCED DISEASE;
DRUG MARKETING;
DRUG MECHANISM;
EPIDEMIC;
HEALTH CARE PERSONNEL;
HIGH RISK POPULATION;
HUMAN;
INFECTION CONTROL;
INFECTION PREVENTION;
INFLUENZA;
INFLUENZA VACCINATION;
INFLUENZA VIRUS A;
INFLUENZA VIRUS B;
NURSING HOME;
PROPHYLAXIS;
SHORT SURVEY;
ADOLESCENT;
ADULT;
AGED;
ANTIVIRAL AGENTS;
CHILD;
CHILD, PRESCHOOL;
FEES, PHARMACEUTICAL;
HUMANS;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
MALE;
MIDDLE AGED;
TIME FACTORS;
|
|
EID: 0035903731
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (1)
|
|
References (0)
|